Global Rheumatology Alliance Registry Will Study COVID-19

Save

In the midst of a global pandemic of the 2019 Novel coronavirus acute respiratory disease (COVID-19), a small handful of Rheumatologists gathered on social media to collectively grapple with the impact of this virus on vulnerable populations with rheumatic disease.

Infusions in the Time of Coronavirus

Save

As they say, necessity is the mother of invention. After years of bemoaning the challenges of telemedicine, our rheumatology clinic transition entirely to a remote clinic in the space of a week.

RheumNow Podcast- COVID Siege (3.20.20)

Save

Dr. Jack Cush reviews the past week of COVID-19 news and advances.

COVID-19 Rheumatology News

Save

With the COVID-19 pandemic dynamically changing, we have provided several news items germane to the Rheumatologist.

In Lupus, Keep BP Below 130/80

Save

Blood pressure should be maintained at a level below 130/80 mm Hg in all patients with lupus to lessen their likelihood of atherosclerotic vascular events, Canadian researchers asserted.

A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Save

Ready for telemedicine/telerheumatology? Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.

The COVID-19 Global Rheumatology Registry

Save

As the highly virulent SARS-CoV-2 spreads over the world, uncertainty and fear for our patients with rheumatic diseases mount.  

Rheumatic Disease Drugs and COVID-19

Save

We are in the early stages of trying to limit the morbid and mortal consequences of the corona virus pandemic of 2020. Not surprisingly, the recommendations designed to limit exposure and damage continually highlight the fact that the elderly and immunosuppressed may be amongst the most severely affected should they become infected with this virus. This has led to a great deal of uncertainty by patients and providers about how rheumatic diseases and their treatments need to be specifically addressed.

In Vasculitis, Beware of Infection

Save

Risks of infection were strikingly high among patients with antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, which may relate to both the disease and its treatment, Scottish researchers found.

RheumNow Podcast- Corona Increases RA Risk (3.13.20)

Save

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Earlier Anakinra Initiation Warranted in Still's Disease

Save

An Italian study examined the outcomes in adult onset Still's disease (AOSD) based on whether they received early or delayed treatment with anakinra (ANK). 

A total of 141 AOSD patients were retrospectively studied.

Switching Biologics in JIA

Save

While there are numerous agents approved for use in juvenile idiopathic arthritis, little is know about actual use biological disease-modifying antirheumatic drug (DMARD) use or switching in the biologic era. A cohort comparison study has shown that after an unsuccessful trial of a first biologic, changing to a second TNFi is as effective as switching to a non-TNFi biologic.